Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (71-80 of 361) with videos related to

Pageof 37
Sort By:
Menopause (New York, N.Y.)|July 19, 2018
Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomyJessica L Chan, Suneeta Senapati, Lauren N C Johnson, et al.
Breast Cancer Research and Treatment|May 9, 2018
Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologistsYonina R Murciano-Goroff, Anne Marie McCarthy, Mirar N Bristol, et al.
Journal of Genetic Counseling|November 1, 2016
Reproductive Decision-Making in Women with BRCA1/2 MutationsJessica L Chan, Lauren N C Johnson, Mary D Sammel, et al.
Nature Reviews. Clinical Oncology|June 15, 2016
Counselling framework for moderate-penetrance cancer-susceptibility mutationsNadine Tung, Susan M Domchek, Zsofia Stadler, et al.
Gynecologic Oncology|February 15, 2021
What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomyMartha Hickey, Katrina M Moss, Alison Brand, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2013
Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviorsKaren Glanz, Kathryn Volpicelli, Peter A Kanetsky, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 2, 2018
A counseling framework for moderate-penetrance colorectal cancer susceptibility genesBryson W Katona, Matthew B Yurgelun, Judy E Garber, et al.
Gynecologic Oncology|October 23, 2024
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-oophorectomy (RRSO)Martha Hickey, Alison H Trainer, Efrosinia O Krejany, et al.
BMC Health Services Research|June 2, 2018
Medical oncologists' willingness to participate in bundled payment programsYonina R Murciano-Goroff, Anne Marie McCarthy, Mirar N Bristol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast CancerAnne Marie McCarthy, Mirar Bristol, Susan M Domchek, et al.
Pageof 37

Showing results (71-80 of 361) with videos related to

Sort By:
Pageof 37
Menopause (New York, N.Y.)|July 19, 2018
Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomyJessica L Chan, Suneeta Senapati, Lauren N C Johnson, et al.
Breast Cancer Research and Treatment|May 9, 2018
Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologistsYonina R Murciano-Goroff, Anne Marie McCarthy, Mirar N Bristol, et al.
Journal of Genetic Counseling|November 1, 2016
Reproductive Decision-Making in Women with BRCA1/2 MutationsJessica L Chan, Lauren N C Johnson, Mary D Sammel, et al.
Nature Reviews. Clinical Oncology|June 15, 2016
Counselling framework for moderate-penetrance cancer-susceptibility mutationsNadine Tung, Susan M Domchek, Zsofia Stadler, et al.
Gynecologic Oncology|February 15, 2021
What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomyMartha Hickey, Katrina M Moss, Alison Brand, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2013
Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviorsKaren Glanz, Kathryn Volpicelli, Peter A Kanetsky, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 2, 2018
A counseling framework for moderate-penetrance colorectal cancer susceptibility genesBryson W Katona, Matthew B Yurgelun, Judy E Garber, et al.
Gynecologic Oncology|October 23, 2024
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-oophorectomy (RRSO)Martha Hickey, Alison H Trainer, Efrosinia O Krejany, et al.
BMC Health Services Research|June 2, 2018
Medical oncologists' willingness to participate in bundled payment programsYonina R Murciano-Goroff, Anne Marie McCarthy, Mirar N Bristol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2016
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast CancerAnne Marie McCarthy, Mirar Bristol, Susan M Domchek, et al.
Pageof 37